logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shivani Srivastava

Fred Hutchinson Cancer Center
H指数:28
被引数:4,848

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target (vol 132, e157101, 2022)
JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2024-08-150
OAAI
Le, Quy; Hadland, Brandon; Smith, Jenny L.; Leonti, Amanda; Huang, Benjamin J.; Ries, Rhonda; Hylkema, Tiffany A.; Castro, Sommer; Tang, Thao T.; Mckay, Cyd N.; Perkins, Lakeisha; Pardo, Laura; Sarthy, Jay; Beckman, Amy K.; Williams, Robin; Idemmili, Rhonda; Furlan, Scott; Ishida, Takashi; Call, Lindsey; Srivastava, Shivani; Loeb, Anisha M.; Milano, Filippo; Imren, Suzan; Morris, Shelli M.; Pakiam, Fiona; Olson, Jim M.; Loken, Michael R.; Brodersen, Lisa; Riddell, Stanley R.; Tarlock, Katherine; Bernstein, Irwin D.; Loeb, Keith R.; Meshinchi, Soheil
A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models
JCI INSIGHT
IF6.1
2024-06-181
OA
Stabach, Paul R.; Sims, Dominique; Gomez-Banuelos, Eduardo; Zehentmeier, Sandra; Dammen-Brower, Kris; Bernhisel, Andrew; Kujawski, Sophia; Lopez, Sam G.; Petri, Michelle; Goldman, Daniel W.; Lester, Ethan R.; Le, Quan; Ishaq, Tayyaba; Kim, Hana; Srivastava, Shivani; Kumar, Deepika; Pereira, Joao P.; Yarema, Kevin J.; Koumpouras, Fotios; Andrade, Felipe; Braddock, Demetrios T.
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
NATURE COMMUNICATIONS
IF15.7
2023-04-1138
OAAI
Bhatia, Vipul; Kamat, Nikhil V.; Pariva, Tiffany E.; Wu, Li-Ting; Tsao, Annabelle; Sasaki, Koichi; Sun, Huiyun; Javier, Gerardo; Nutt, Sam; Coleman, Ilsa; Hitchcock, Lauren; Zhang, Ailin; Rudoy, Dmytro; Gulati, Roman; Patel, Radhika A.; Roudier, Martine P.; True, Lawrence D.; Srivastava, Shivani; Morrissey, Colm M.; Haffner, Michael C.; Nelson, Peter S.; Priceman, Saul J.; Ishihara, Jun; Lee, John K.
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2022-11-1522
OAAI
Le, Quy; Hadland, Brandon; Smith, Jenny L.; Leonti, Amanda; Huang, Benjamin J.; Ries, Rhonda; Hylkema, Tiffany A.; Castro, Sommer; Tang, Thao T.; McKay, Cyd N.; Perkins, LaKeisha; Pardo, Laura; Sarthy, Jay; Beckman, Amy K.; Williams, Robin; Idemmili, Rhonda; Furlan, Scott; Ishida, Takashi; Call, Lindsey; Srivastava, Shivani; Loeb, Anisha M.; Milano, Filippo; Imren, Suzan; Morris, Shelli M.; Pakiam, Fiona; Olson, Jim M.; Loken, Michael R.; Brodersen, Lisa; Riddell, Stanley R.; Tarlock, Katherine; Bernstein, Irwin D.; Loeb, Keith R.; Meshinchi, Soheil
A phase I study of adoptive immunotherapy for ROR1+advanced triple negative breast cancer (TNBC) with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)

ROR1晚期三阴性乳腺癌 (TNBC) 的过继免疫治疗的I期研究，其中定义了表达ROR1-specific嵌合抗原受体 (ROR1-CAR) 的自体T细胞亚群

CANCER RESEARCH
IF16.6
2019-02-1522
PRE
Specht, J. M.; Lee, S. M.; Turtle, C.; Berger, C.; Balakrishnan, A.; Srivastava, S.; Viollet, V.; Veatch, J.; Gooley, T.; Mullane, E.; Chaney, C. N.; Rader, C.; Pierce, R. H.; Gottardo, R.; Maloney, D. G.; Riddell, S. R.
A phase I study of adoptive immunotherapy for advanced ROR1+malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)

具有表达ROR1-specific嵌合抗原受体 (ROR1-CAR) 的自体T细胞亚群的晚期ROR1恶性肿瘤过继免疫治疗的I期研究

CANCER RESEARCH
IF16.6
2018-07-0117
PRE
Specht, Jennifer M.; Lee, Sylvia; Turtle, Cameron J.; Berger, Carolina; Baladrishnan, Ashwini; Srivastava, Shivani; Voillet, Valentin; Veatch, Josh; Gooley, Ted; Mullane, Erin; Chaney, Colette; Rader, Christoph; Pierce, Robert H.; Gottardo, Raphael; Maloney, David G.; Riddell, Stanley R.
Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced refractory solid tumors
ANNALS OF ONCOLOGY
IF65.4
2016-10-018
OAAI
Segal, N. H.; Infante, J. R.; Sanborn, R. E.; Gibney, G. T.; Lawrence, D. P.; Rizvi, N.; Leidner, R.; Gajewski, T. F.; Bertino, E.; Sharfman, W. H.; Cooley, S.; Topalian, S. L.; Urba, W. J.; Wolchok, J. D.; Gu, X.; Passey, C.; McDonald, D.; Aanur, P.; Srivastava, S.; Hodi, F. S.

研究方向

暂未获取到该数据
S
Stanley R. Riddell
H 指数:111论文数:559被引数:4.9万
D
Daniel Campbell
H 指数:60论文数:404被引数:1.6万
L
Lindsey Call
H 指数:5论文数:13被引数:138
Q
Quy Le
H 指数:10论文数:57被引数:372
W
W. Sam Nutt
H 指数:2论文数:7被引数:128
S
Soheil Meshinchi
H 指数:65论文数:850被引数:2.2万
K
Kate S. Smigiel
H 指数:10论文数:23被引数:1,492
J
Jenny L. Smith
H 指数:22论文数:138被引数:2,377
S
Sommer Castro
H 指数:5论文数:24被引数:169
T
Thao T. Tang
H 指数:6论文数:40被引数:217